BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

362 related articles for article (PubMed ID: 17914075)

  • 1. Absence of conclusive evidence for the safety and efficacy of gonadotropin-releasing hormone analogue treatment in protecting against chemotherapy-induced gonadal injury.
    Oktay K; Sönmezer M; Oktem O; Fox K; Emons G; Bang H
    Oncologist; 2007 Sep; 12(9):1055-66. PubMed ID: 17914075
    [TBL] [Abstract][Full Text] [Related]  

  • 2. How to preserve fertility in young women exposed to chemotherapy? The role of GnRH agonist cotreatment in addition to cryopreservation of embrya, oocytes, or ovaries.
    Blumenfeld Z
    Oncologist; 2007 Sep; 12(9):1044-54. PubMed ID: 17914074
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevention of gonadal damage during cytotoxic therapy.
    Blumenfeld Z; Haim N
    Ann Med; 1997 Jun; 29(3):199-206. PubMed ID: 9240625
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assisted reproduction and fertility preservation techniques in cancer patients.
    Sönmezer M; Oktay K
    Curr Opin Endocrinol Diabetes Obes; 2008 Dec; 15(6):514-22. PubMed ID: 18971680
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gender difference: fertility preservation in young women but not in men exposed to gonadotoxic chemotherapy.
    Blumenfeld Z
    Minerva Endocrinol; 2007 Mar; 32(1):23-34. PubMed ID: 17353864
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Commentary: Ovarian function does not equal fertility does not equal babies.
    Moore HC; Theriault RL
    Oncologist; 2007 Sep; 12(9):1067-9. PubMed ID: 17914076
    [No Abstract]   [Full Text] [Related]  

  • 7. Chemotherapy-induced female infertility and protective action of gonadotropin-releasing hormone analogues.
    Imai A; Furui T
    J Obstet Gynaecol; 2007 Jan; 27(1):20-4. PubMed ID: 17365452
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chemotherapy and amenorrhea: risks and treatment options.
    Oktay K; Sönmezer M
    Curr Opin Obstet Gynecol; 2008 Aug; 20(4):408-15. PubMed ID: 18660694
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gonadotropin-releasing hormone agonist decreases chemotherapy-induced gonadotoxicity and premature ovarian failure in young female patients with Hodgkin lymphoma.
    Blumenfeld Z; Avivi I; Eckman A; Epelbaum R; Rowe JM; Dann EJ
    Fertil Steril; 2008 Jan; 89(1):166-73. PubMed ID: 17601603
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Breast cancer and fertility: critical review, considerations and perspectives].
    This P
    Bull Cancer; 2008 Jan; 95(1):17-25. PubMed ID: 18230566
    [TBL] [Abstract][Full Text] [Related]  

  • 11. GnRH agonist therapy as ovarian protectants in female patients undergoing chemotherapy: a review of the clinical data.
    Beck-Fruchter R; Weiss A; Shalev E
    Hum Reprod Update; 2008; 14(6):553-61. PubMed ID: 18820006
    [TBL] [Abstract][Full Text] [Related]  

  • 12. GnRH-analogues and oral contraceptives for fertility preservation in women during chemotherapy.
    Blumenfeld Z; von Wolff M
    Hum Reprod Update; 2008; 14(6):543-52. PubMed ID: 18824495
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Techniques for fertility preservation in patients with breast cancer.
    Dunn L; Fox KR
    Curr Opin Obstet Gynecol; 2009 Feb; 21(1):68-73. PubMed ID: 19125006
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preservation of gonadal function in women undergoing chemotherapy: a review of the potential role for gonadotropin-releasing hormone agonists.
    Hickman LC; Valentine LN; Falcone T
    Am J Obstet Gynecol; 2016 Oct; 215(4):415-22. PubMed ID: 27422055
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Response to "Absence of conclusive evidence for the safety and efficacy of gonadotropin-releasing hormone analogue treatment in protecting against chemotherapy-induced gonadal injury".
    Somers EC; Christman GM; Fisseha S; Marder W; McCune WJ
    Oncologist; 2008 May; 13(5):613-4; author reply 615-7. PubMed ID: 18581656
    [No Abstract]   [Full Text] [Related]  

  • 16. Ovarian function preservation by GnRH agonists during chemotherapy.
    Blumenfeld Z
    J Womens Health (Larchmt); 2009 Sep; 18(9):1471; author reply 1473. PubMed ID: 19708807
    [No Abstract]   [Full Text] [Related]  

  • 17. Gonadal failure with cyclophosphamide therapy for lupus nephritis: advances in fertility preservation.
    Mersereau J; Dooley MA
    Rheum Dis Clin North Am; 2010 Feb; 36(1):99-108, viii. PubMed ID: 20202593
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Do GnRH analogs protect against ovarian toxicity of chemotherapy?
    Moore HC
    Breast Cancer Res Treat; 2009 Oct; 117(3):569-70. PubMed ID: 19234783
    [No Abstract]   [Full Text] [Related]  

  • 19. Assisted reproduction and breast cancer.
    Sonmezer M; Atabekoglu C
    Minerva Ginecol; 2007 Aug; 59(4):403-14. PubMed ID: 17923831
    [TBL] [Abstract][Full Text] [Related]  

  • 20. GnRH-agonists in fertility preservation.
    Blumenfeld Z
    Curr Opin Endocrinol Diabetes Obes; 2008 Dec; 15(6):523-8. PubMed ID: 18971681
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.